Presentation is loading. Please wait.

Presentation is loading. Please wait.

Promoting and Accelerating New Evolving Nuclear Nano-Molecular PET/SPECT Imaging Technologies and Related Cyclotron Technologies in the Region Sang.

Similar presentations


Presentation on theme: "Promoting and Accelerating New Evolving Nuclear Nano-Molecular PET/SPECT Imaging Technologies and Related Cyclotron Technologies in the Region Sang."— Presentation transcript:

1 Promoting and Accelerating New Evolving Nuclear Nano-Molecular PET/SPECT Imaging Technologies and Related Cyclotron Technologies in the Region Sang Eun Kim, M.D., Ph.D. Professor and Chairman Department of Nuclear Medicine and Molecular Imaging Seoul National University Bundang Hospital Republic of Korea

2 Ageing Society Increasing life expectancy: World
Increasing life expectancy: Regions World Population Ageing , United Nations

3 Ageing Society Percentage of population 60 years and older
Fertility Transition and Population Ageing in the Asian and Pacific Region, High level Meeting on the Regional Review of MIPAA, 2007

4 Alzheimer’s Disease Facts and Figures, 2007, Alzheimer’s Association
Annual Report 2007–2008, Alzheimer’s Disease International

5 Prevalence of dementia (%) by WHO region and age group
The letters in brackets refer to the level of development of the region; A= lowest mortality regions; E=highest mortality regions Alzheimer’s Disease International fact sheet 2008, Alzheimer’s Disease International

6 Estimated Global Cancer Burden
(Numbers of new cases of cancer per annum) World Cancer Report 2008, WHO

7 Cancer incidence and mortality in the six WHO world areas
AFRO: Africa: EMRO: East Mediterranean; EURO: Europe; PAHO: PanAmerican; SEARO: South-East Asia; WPRO: Western Pacific SEARO WPRO World Cancer Report 2008, WHO

8 Estimated and projected numbers (millions) of cancer cases and deaths
World Cancer Report 2008, WHO

9 Nuclear Nano-Molecular PET/SPECT Imaging
See what is happening in living body at molecular levels High sensitivity and target-specificity Non-invasive and longitudinal monitoring Quantitative Cost-effective New paradigm in medicine Personalized medicine Wide applicability Useful for the detection and monitoring of neurodegenerative diseases (e.g., Parkinson’s disease, Alzheimer’s disease) and cancers

10 Nuclear Nano-Molecular PET/SPECT Imaging
Alzheimer’s disease Healthy individual Parkinson’s disease Whole body PK Target PK/PD Advanced cancer

11 Technical Disparities in the Region
Developing Countries Developed Countries Technology Instrumentation and Facility Human Resources

12 Technical Disparities in the Region (Number per million population)
Institutions Members Gamma cameras Studies PET Cyclotron (Number per million population) (Number) Japan 9.4 24 14762 350 150 Korea 2.5 3.3 4.7 11480 100 25 China 0.6 3.1 384 120 53 Philippines 0.2 0.3 551 2(3) 1 Thailand 0.7 0.4 328 4 Vietnam 113 3 Indonesia 0.07 0.09 0.14 88 Malaysia 2

13 Solving the Problems (Aims of this project)
Raise-up facilities and instrumentation Enhance knowledge and technologies Enrich human resources Promote inter-regional/international cooperation Increase support from international organizations (RCA, IAEA, UNDP, etc.)

14 Specific objectives Promote and accelerate new evolving nuclear nano-molecular PET/SPECT imaging technologies and related cyclotron technologies Enhance neurochemistry imaging and molecular oncologic imaging technologies Setup learning, training and hands-on practice courses Establish a network of experts and facilities in the Region Foster the capability of research and development

15 Strategies Train-the-Trainers On-site regional workshops
Hands-on practices Interactive and customized training courses Intra/inter-regional networking (including local and central offices) In-depth evaluation and feedback

16 Transferable technologies involved
Pathophysiology relevant to nano-molecular imaging Nano-molecular probe production from cyclotron Image acquisition and reconstruction Image analysis/interpretation and clinical applications Neurochemistry imaging technologies (e.g., Dopaminergic, serotonergic, cholinergic neurotransmitter system and amyloid plaque imaging) Molecular oncologic imaging technologies (e.g., Imaging of angiogenesis, membrane lipid synthesis, cell proliferation, tumor cell receptor, hypoxia, and other metabolic processes)

17 Detailed plans Jan - Mar Apr - Jun Jul - Sep Oct - Dec 2010
Expert meetings for training course protocol Completion of protocols Training courses #1,2 (4 wks each) Training courses #3,4 (4 wks each) 2011 Training course #5 (4 wks) Interim evaluation and report On-site regional workshop #1 Hands-on practices #1 (short-term) 2012 Hands-on practices #2 On-site regional workshop #2 Intra/inter-regional networking (including local and central offices setup) Final evaluation and report

18 Expected impact of the project
Contribute to the progress of clinical sciences Augment the cyclotron application technologies and maximize the use of cyclotrons Enrich basic and applied science capabilities in the Region

19 Strategies for the sustainability of the project
Training courses that are interactive and customized to needs of the region and the trainees Establishment of expert networks Interactive web-based systems Persistent operation of local and central offices after the completion of the project

20 SNUBH Nuclear Nano-Molecular Imaging Center
Radiochemistry Nano-Molecular Imaging Image Analysis/ Interpretation 3 PhDs 4 MS researchers 2 MDs 2 PhDs 5 MS researchers 3 MDs 1 PhD 4 MS researchers Synthesis and development of disease/target-specific nano- molecules and molecular imaging probes Nano-molecular imaging QA Animal models Human volunteers Imaging protocols and QA Image analysis/quantification and applications Biological interpretation Cyclotron Research Center Nano-Molecular Imaging Facilities Image Lab

21 Major Facilities and Equipments
Cyclotron Hot cells Chemistry lab PET/CT Gas anesthesia Dedicated animal holder Translation storage NanoSPECT for animal imaging NanoPET for animal imaging Dedicated animal imaging chamber Ventilated animal cage racks SPECT

22 Coordinator and active key members of the project lead country
Sang Eun Kim, M.D., Ph.D. Professor and Chairman Department of Nuclear Medicine and Molecular Imaging Seoul National University Bundang Hospital Republic of Korea WW Lee, MD, PhD YK Kim, MD. PhD BC Lee, PhD YS Lee, PhD JJ Lee, MD C Kim, MD BS Moon, PhD


Download ppt "Promoting and Accelerating New Evolving Nuclear Nano-Molecular PET/SPECT Imaging Technologies and Related Cyclotron Technologies in the Region Sang."

Similar presentations


Ads by Google